Global News and Digital Insights
for the Consumer Goods Industry

J&J is planning to focus on pharmaceuticals instead of consumer health products



Johnson & Johnson plans to focus more on pharmaceutical and medical devices instead of consumer health products like Listerine and baby powder. The brand aims to separate the categories in 18 to 24 months and it will invest $500 million-$1 billion. The pharmaceutical and medical devices would preserve the company’s name, while J&J would spin-off without paying tax. Although consumer health products have been the top-notch items of the company, the pharmaceutical and medical equipment, including cancer treatments, vaccines, and surgical tools, are anticipated to make $80 billion in sales this year.

Read more from Reuters